Early-Stage Technology Assessment

Be confident in your investment decisions - evaluate the commercial potential of healthcare technology in development through the IHE Early-Stage Life Sciences Technology Assessment service.

The IHE provides services for early-stage small- and medium-sized enterprise (SME) technology developers (or other innovators, such as an academic group considering forming an SME) to present important insights into the potential for commercial success. This includes an assessment of the health economic evidentiary requirements and hurdles that will need to be met and overcome to market a technology that is attractive to payers. Insights from IHE services will support decision-making on the merits of further product development or modifications in design to improve the value offering, and will assist with raising capital.

IHE Early-Stage Life Sciences Technology Assessment:

Key Benefits

  • Save time, money, and intellectual resources by identifying technologies that are unlikely to be commercially successful.
  • Understand how to design or adjust an R&D/evidence development program to increase the likelihood of commercial success.
  • Obtain a robust assessment of commercial potential for use in raising capital and increasing resources available to the organization.

For more information about IHE service offerings to support life sciences SMEs please contact us at [email protected].

Downloads

SME Early-Stage Health Technology Assessment Brochure